Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Non-Current Debt: 2009-2021

Historic Non-Current Debt for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $142.4 million.

  • Avadel Pharmaceuticals' Non-Current Debt was N/A to $52.5 billion in Q2 2015 from the same period last year, while for Jun 2015 it was $52.5 billion, marking a year-over-year change of. This contributed to the annual value of $52.5 billion for FY2014, which is N/A change from last year.
  • As of FY2014, Avadel Pharmaceuticals' Non-Current Debt stood at $52.5 billion.
  • Avadel Pharmaceuticals' 5-year Non-Current Debt high stood at $52.5 billion for FY2014, and its period low was $52.5 billion during FY2014.
  • Over the past 3 years, Avadel Pharmaceuticals' median Non-Current Debt value was $128.2 million (recorded in 2020), while the average stood at $130.8 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first declined by 25.28% in 2017, then surged by 56.57% in 2018.
  • Over the past 5 years, Avadel Pharmaceuticals' Non-Current Debt (Yearly) stood at $73.9 million in 2017, then surged by 56.57% to $115.7 million in 2018, then rose by 5.14% to $121.7 million in 2019, then increased by 5.36% to $128.2 million in 2020, then rose by 11.07% to $142.4 million in 2021.